Welcoming John Devine as Orthoplastics' New Managing Director
We're delighted to welcome John Devine as the new Managing Director of Orthoplastics. He brings more than 20 years of leadership experience across the global medical device and biomaterials sectors, and has a wealth of expertise in commercial strategy, innovation and operational excellence.
John succeeds Rodney Crooks as part of a planned leadership transition at Orthoplastics. Rodney will return to the US to take on new responsibilities within the wider business, further details will be shared in due course.
John will lead Orthoplastics through its next phase of growth, with a strong focus on strengthening customer partnerships, driving innovation and continuing to deliver world-class implantable-grade polymer solutions to the orthopaedic industry.
Speaking about his appointment, John said: "I'm excited to join Orthoplastics at such an important time for the business. Orthoplastics has built an outstanding reputation for quality, innovation and customer collaboration, and I look forward to working closely with the team and our customers to support continued growth and long-term success."
A Trusted Leader in Biomaterials and Medical Manufacturing
Before joining Orthoplastics, John was Managing Director at Invibio. He led the company’s PEEK-based medical manufacturing operations, including additive manufacturing. While there, he expanded the business into important international markets and grew the biomaterials unit to record revenues.
John also strengthened collaboration with key customers, expanded sales within strategic accounts and improved service and quality across multiple geographic regions. Before Invibio, he held several senior leadership positions at Victrex, including Medical Business Unit Director, Emerging Business Director and Strategic Marketing and Technology Director.
John holds a PhD in Polymer Chemistry, an MSc in Process Technology and Management and a BSc in Chemistry. He is widely recognised for his practical, partnership-led approach and his commitment to quality, reliability and long-term customer success.
Looking Ahead at Orthoplastics
John's appointment marks an exciting next step for the business as it continues to build on its reputation for quality, collaboration and technical expertise.
Speaking about his new role, John said: "Orthoplastics is uniquely positioned, and I look forward to building on the company's strong foundations. My focus will be on supporting our customers, advancing innovation and ensuring Orthoplastics continues to lead the way in high-performance biomaterials."
We would also like to thank Rodney Crooks for his leadership and contribution to Orthoplastics during his time as Managing Director and wish him every success in his new role.
Please join us in congratulating John on his appointment and welcoming him to Orthoplastics.
Go Back
